126 related articles for article (PubMed ID: 38581222)
1. Topical isoniazid as a novel treatment for melasma: A randomized, double-blind, vehicle-controlled clinical trial.
Ahramiyanpour N; Mahmoudi Z; Nezhad NZ; Khazaeli P; Amiri R; Kasraee B
J Cosmet Dermatol; 2024 Apr; ():. PubMed ID: 38581222
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of
Goh CL; Chuah SY; Tien S; Thng G; Vitale MA; Delgado-Rubin A
J Clin Aesthet Dermatol; 2018 Mar; 11(3):14-19. PubMed ID: 29606995
[No Abstract] [Full Text] [Related]
3. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial.
Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial.
Lima PB; Dias JAF; Cassiano DP; Esposito ACC; Miot LDB; Bagatin E; Miot HA
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1881-1887. PubMed ID: 33988887
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy and Safety on Combining 20% Trichloroacetic Acid Peel with Topical 5% Ascorbic Acid for Melasma.
Dayal S; Sahu P; Yadav M; Jain VK
J Clin Diagn Res; 2017 Sep; 11(9):WC08-WC11. PubMed ID: 29207818
[TBL] [Abstract][Full Text] [Related]
7. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
8. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
Farshi S; Mansouri P; Kasraee B
J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
[TBL] [Abstract][Full Text] [Related]
10. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
[TBL] [Abstract][Full Text] [Related]
12. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
Sepaskhah M; Karimi F; Bagheri Z; Kasraee B
J Cosmet Dermatol; 2022 Jul; 21(7):2871-2878. PubMed ID: 35510765
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
[TBL] [Abstract][Full Text] [Related]
15. Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial.
de Amorim RP; Barbosa MMC; Cassiano DP; Esposito ACC; Dias MO; de Abreu AFT; Bagatin E; Miot HA
Int J Dermatol; 2024 Feb; ():. PubMed ID: 38411257
[TBL] [Abstract][Full Text] [Related]
16. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: A randomized, double-blind clinical trial study.
Karrabi M; David J; Sahebkar M
Skin Res Technol; 2021 Jan; 27(1):24-31. PubMed ID: 32585079
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.
Lyons A; Stoll J; Moy R
J Drugs Dermatol; 2018 Sep; 17(9):970-973. PubMed ID: 30235384
[TBL] [Abstract][Full Text] [Related]
19. Effects of trans-4-(aminomethyl) cyclohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double-blind, controlled study.
Viyoch J; Tengamnuay I; Phetdee K; Tuntijarukorn P; Waranuch N
Curr Ther Res Clin Exp; 2010 Dec; 71(6):345-59. PubMed ID: 24688154
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a topical Unani pharmacopoeial formulation
Salma ; Shamsi Y; Nikhat S; Manjhi M; Akhtar MW; Ahmad S
Avicenna J Phytomed; 2023; 13(3):255-264. PubMed ID: 37654999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
